Skip to main content
Top
Published in: Respiratory Research 1/2016

Open Access 01-12-2016 | Research

c.3623G > A mutation encodes a CFTR protein with impaired channel function

Authors: Xiaoying Zhang, Jaspal S. Hothi, Yanhui H. Zhang, Saumini Srinivasan, Dennis C. Stokes, Weiqiang Zhang

Published in: Respiratory Research | Issue 1/2016

Login to get access

Abstract

Background

The aims of this study were to characterize clinical features of a pediatric African-American cystic fibrosis (CF) patient heterozygous for F508del and a novel c.3623G > A mutation, and to identify the molecular defect(s) associated with c.3623G > A mutation.

Methods

The medical record of this patient was analyzed retrospectively. Western blotting and iodide efflux assay were used to study mutant CFTR protein expression level, maturation status, channel function, and the effects of CFTR modulation on these characteristics.

Results

The encoding protein of c.3623G > A mutation, G1208D-CFTR, has a moderate processing defect and exhibits impaired channel function, which were partially rescued by using VX-809 or exposed to low temperature (28 °C). The patient has mild CF disease manifestations.

Conclusions

Our biochemical findings correlate with the clinical phenotype and suggest that c.3623G > A is a CF-causing mutation. The study helps expand our knowledge of rare CFTR mutations in a minority population and may have important clinical implications for personalized therapeutic intervention.
Literature
1.
go back to reference Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 1990;63:827–34.CrossRefPubMed Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 1990;63:827–34.CrossRefPubMed
2.
go back to reference Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73:1251–4.CrossRefPubMed Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73:1251–4.CrossRefPubMed
5.
go back to reference Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066–73.CrossRefPubMed Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066–73.CrossRefPubMed
6.
go back to reference Anderson MP, Gregory RJ, Thompson S, Souza DW, Paul S, Mulligan RC, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science. 1991;253:202–5.CrossRefPubMed Anderson MP, Gregory RJ, Thompson S, Souza DW, Paul S, Mulligan RC, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science. 1991;253:202–5.CrossRefPubMed
7.
go back to reference Bear CE, Li CH, Kartner N, Bridges RJ, Jensen TJ, Ramjeesingh M, et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 1992;68:809–18.CrossRefPubMed Bear CE, Li CH, Kartner N, Bridges RJ, Jensen TJ, Ramjeesingh M, et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 1992;68:809–18.CrossRefPubMed
8.
go back to reference Clancy JP, Jain M. Personalized medicine in cystic fibrosis: dawning of a new era. Am J Respir Crit Care Med. 2012;186:593–7.CrossRefPubMed Clancy JP, Jain M. Personalized medicine in cystic fibrosis: dawning of a new era. Am J Respir Crit Care Med. 2012;186:593–7.CrossRefPubMed
13.
go back to reference Sweat Testing: Sample Collection and Quantitative Analysis; Approved Guideline-Second Edition. NCCLS document C34-A2.Wayne (PA): NCCLS; 2000. Sweat Testing: Sample Collection and Quantitative Analysis; Approved Guideline-Second Edition. NCCLS document C34-A2.Wayne (PA): NCCLS; 2000.
14.
go back to reference Yarlagadda S, Zhang W, Penmatsa H, Ren A, Arora K, Naren AP, et al. A young Hispanic with c.1646G > A mutation exhibits severe cystic fibrosis lung disease: is ivacaftor an option for therapy? Am J Respir Crit Care Med. 2012;186:694–6.PubMedCentralCrossRefPubMed Yarlagadda S, Zhang W, Penmatsa H, Ren A, Arora K, Naren AP, et al. A young Hispanic with c.1646G > A mutation exhibits severe cystic fibrosis lung disease: is ivacaftor an option for therapy? Am J Respir Crit Care Med. 2012;186:694–6.PubMedCentralCrossRefPubMed
15.
go back to reference Van Goor F, Hadida S, Grootenhuis PD, Burton B, Stack JH, Straley KS, et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A. 2011;108:18843–8.PubMedCentralCrossRefPubMed Van Goor F, Hadida S, Grootenhuis PD, Burton B, Stack JH, Straley KS, et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A. 2011;108:18843–8.PubMedCentralCrossRefPubMed
16.
go back to reference Rohlfs EM, Zhou Z, Heim RA, Nagan N, Rosenblum LS, Flynn K, et al. Cystic fibrosis carrier testing in an ethnically diverse US population. Clin Chem. 2011;57:841–8.CrossRefPubMed Rohlfs EM, Zhou Z, Heim RA, Nagan N, Rosenblum LS, Flynn K, et al. Cystic fibrosis carrier testing in an ethnically diverse US population. Clin Chem. 2011;57:841–8.CrossRefPubMed
17.
go back to reference Sugarman EA, Rohlfs EM, Silverman LM, Allitto BA. CFTR mutation distribution among Hispanic US and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet Med. 2004;6:392–9.CrossRefPubMed Sugarman EA, Rohlfs EM, Silverman LM, Allitto BA. CFTR mutation distribution among Hispanic US and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet Med. 2004;6:392–9.CrossRefPubMed
18.
go back to reference Ramsey BW, Banks-Schlegel S, Accurso FJ, Boucher RC, Cutting GR, Engelhardt JF, et al. Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report. Am J Respir Crit Care Med. 2012;185:887–92.PubMedCentralCrossRefPubMed Ramsey BW, Banks-Schlegel S, Accurso FJ, Boucher RC, Cutting GR, Engelhardt JF, et al. Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report. Am J Respir Crit Care Med. 2012;185:887–92.PubMedCentralCrossRefPubMed
Metadata
Title
c.3623G > A mutation encodes a CFTR protein with impaired channel function
Authors
Xiaoying Zhang
Jaspal S. Hothi
Yanhui H. Zhang
Saumini Srinivasan
Dennis C. Stokes
Weiqiang Zhang
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2016
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-016-0326-7

Other articles of this Issue 1/2016

Respiratory Research 1/2016 Go to the issue